Increased pfmdr1 copy number and sequence polymorphisms in lasmodium falciparum Isolates from Sudanese malaria patients treated with artemether-lumefantrine

Gadalla, Nahla B., Adam, Ishag, Elzaki, Salah-Eldin, Bashir, Sahar, Mukhtar, Izdihar, Oguike, Mary, Gadalla, Amal ORCID: https://orcid.org/0000-0002-3131-725X, Mansour, Fathi, Warhurst, David, El-Sayed, Badria B. and Sutherland, Colin J. 2011. Increased pfmdr1 copy number and sequence polymorphisms in lasmodium falciparum Isolates from Sudanese malaria patients treated with artemether-lumefantrine. Antimicrobial Agents and Chemotherapy 55 (11) , pp. 5408-5411. 10.1128/AAC.05102-11

PDF - Accepted Post-Print Version Download (464kB)

Abstract

Molecular markers for surveillance of Plasmodium falciparum resistance to current antimalarials are sorely needed. A 28-day efficacy study of artemether-lumefantrine in eastern Sudan identified 5 treatment failures among 100 evaluable patients; 9 further individuals were parasite positive by PCR during follow-up. Polymorphisms in pfatpase6 and pfmdr1 were evaluated by DNA sequencing. One individual carried parasites with a novel pfmdr1 polymorphism (F1044L). pfmdr1 gene amplification in parasites prior to treatment occurred in three individuals who had recurrent infection during follow-up.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	American Society for Microbiology
ISSN:	0066-4804
Date of First Compliant Deposit:	15 January 2021
Date of Acceptance:	24 August 2011
Last Modified:	05 May 2023 07:38
URI:	https://orca.cardiff.ac.uk/id/eprint/137632

Citation Data

Cited 53 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item